EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Group 3 Innate Lymphoid Cells: A Potential Therapeutic Target for Steroid Resistant Asthma

Marzhan Berkinbayeva, Wenjing Gu, Zhifeng Chen, Peisong Gao

Clinical Reviews in Allergy & Immunology · 27.12.2024 · 68 (1)

DOI: 10.1007/s12016-024-09012-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Reviews in Allergy & Immunology, online erschienen am 27.12.2024. Verfasst von Marzhan Berkinbayeva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Clinical Immunology, The Johns Hopkins Asthma & Allergy Center, Johns Hopkins University School of Medicine, 5501 Hopkins Bay…. Hauptthemen laut MEDLINE: Asthma, Immunity, Innate, Drug Resistance, Lymphocytes. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Asthma is a chronic airway inflammatory disease that affects millions globally. Although glucocorticoids are a mainstay of asthma treatment, a subset of patients show resistance to these therapies, resulting in poor disease control and increased morbidity. The complex mechanisms underlying steroid-resistant asthma (SRA) involve Th1 and Th17 lymphocyte activity, neutrophil recruitment, and NLRP3 inflammasome activation. Recent studies provided evidence that innate lymphoid cells type 3 (ILC3s) might be potential therapeutic targets for non-eosinophilic asthma (NEA) and SRA. Like Th17 cells, ILC3s play crucial roles in immune responses, inflammation, and tissue homeostasis, contributing to disease severity and corticosteroid resistance in NEA. Biologics targeting ILC3-related pathways have shown promise in managing Th2-low asthma, suggesting new avenues for SRA treatment. This review aims to explore the risk factors for SRA, discuss the challenges and mechanisms underlying SRA, consolidate current findings on innate lymphoid cells, and elucidate their role in respiratory conditions. We present the latest findings on the involvement of ILC3s in human diseases and explore their potential mechanisms in SRA development. Furthermore, we review emerging therapeutic biologics targeting ILC3-related pathways in managing NEA and SRA. This review highlights current challenges, and emerging therapeutic strategies, and addresses a significant gap in asthma research, with implications for improving the management of steroid-resistant asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaImmunity, InnateDrug ResistanceLymphocytesHumansAnimalsAnti-Asthmatic AgentsMolecular Targeted TherapyGlucocorticoidsDisease Susceptibility

Stichwörter der Autor:innen

IL-17ILC3sNon-eosinophilic asthmaSteroid-resistant asthma

Substanzen

Anti-Asthmatic AgentsGlucocorticoids

Autor:innen und Institutionen

  • Division of Allergy and Clinical Immunology, The Johns Hopkins Asthma & Allergy Center, Johns Hopkins University School of Medicine, 5501 Hopkins Bayview Circle, Room 3B.71, Baltimore, MD, 21224, USA.
  • Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Department of Respiratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Division of Allergy and Clinical Immunology, The Johns Hopkins Asthma & Allergy Center, Johns Hopkins University School of Medicine, 5501 Hopkins Bayview Circle, Room 3B.71, Baltimore, MD, 21224, USA. pgao1@jhmi.edu.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Berkinbayeva, M., Gu, W., Chen, Z., & Gao, P. (2024). Group 3 Innate Lymphoid Cells: A Potential Therapeutic Target for Steroid Resistant Asthma. Clinical Reviews in Allergy & Immunology, 68(1). https://doi.org/10.1007/s12016-024-09012-3

Vancouver

Berkinbayeva M, Gu W, Chen Z, Gao P. Group 3 Innate Lymphoid Cells: A Potential Therapeutic Target for Steroid Resistant Asthma. Clinical Reviews in Allergy & Immunology. 2024;68(1). doi:10.1007/s12016-024-09012-3

BibTeX
@article{Berkinbayeva2024,
  author = {Berkinbayeva, Marzhan and Gu, Wenjing and Chen, Zhifeng and Gao, Peisong},
  title = {Group 3 Innate Lymphoid Cells: A Potential Therapeutic Target for Steroid Resistant Asthma},
  journal = {Clinical Reviews in Allergy & Immunology},
  year = {2024},
  volume = {68},
  number = {1},
  doi = {10.1007/s12016-024-09012-3}
}
Kostenlos starten →